Physician profile
Vu A Tran
NPI 1528021490
$26,669.67
in general payments reported to CMS, 2019-2025
37 companies · $5,747 in 2025
The $5,747 reported for 2025 was more than what 94% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,465 · 2020: $1,338 · 2021: $4,022 · 2022: $4,569 · 2023: $4,676 · 2024: $4,854 · 2025: $5,747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Long Term Medical Supply Or Device Loan: $1,561 · Education: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,234.05 |
| Long Term Medical Supply Or Device Loan | $1,560.61 |
| Education | $482.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,193.92 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $4,560.52 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Philips North America LLC | $3,711.01 | 2019-2025 | (8269) Dreamstation Cpap, Vest Therapy Und, (8874) Incourage |
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,455.76 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Genzyme Corporation | $2,112.98 | 2019-2025 | |
| Apria Healthcare LLC | $1,380.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $1,136.21 | 2019-2025 | Dupixent |
| Harmony Biosciences LLC | $658.05 | 2021-2025 | Wakix |
| Baxter Healthcare | $477.81 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Amgen INC. | $444.87 | 2022-2025 | Tezspire |
| Sanofi-Aventis U.S. LLC | $403.42 | 2019-2025 | |
| Grifols USA, LLC | $380.10 | 2019-2024 | Prolastin-C Liquid, Xembify |
| Novartis Pharmaceuticals Corporation | $259.49 | 2019-2025 | |
| Verona Pharma, INC. | $221.47 | 2025 | Ohtuvayre |
| Electromed, INC. | $207.52 | 2021-2025 | Smartvest |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $196.69 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $192.05 | 2020-2023 | Glassia |
| Lilly USA, LLC | $173.49 | 2025 | Zepbound |
| Genentech USA, INC. | $161.39 | 2019-2022 | |
| Noctrix Health, INC. | $148.72 | 2025 | Nidra |
| Insmed, INC. | $135.25 | 2024-2025 | Arikayce |
| Inspire Medical Systems, INC. | $134.00 | 2024-2025 | Inspire |
| Mallinckrodt Hospital Products INC. | $132.76 | 2021 | |
| Abbvie INC. | $125.00 | 2025 | |
| Csl Behring | $117.60 | 2020-2023 | Kcentra |
| Advanced Respiratory, INC | $103.67 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $91.85 | 2020-2025 | |
| Resmed Corp | $75.77 | 2020-2025 | |
| Shire North American Group INC | $71.61 | 2019 | |
| United Therapeutics Corporation | $67.56 | 2024-2025 | Tyvaso, Tyvaso |
| Janssen Pharmaceuticals, INC | $23.78 | 2022 | |
| Merck Sharp & Dohme LLC | $23.77 | 2024 | |
| Avanir Pharmaceuticals, INC. | $23.59 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $18.28 | 2024 | Lumryz |
| Genentech, INC. | $17.93 | 2019 | |
| Mylan Specialty L.P. | $17.20 | 2019 | |
| Fisher & Paykel Healthcare INC | $14.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vu Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.